CN106361875A - Composition with sweating stopping and odor removing functions - Google Patents
Composition with sweating stopping and odor removing functions Download PDFInfo
- Publication number
- CN106361875A CN106361875A CN201610957004.8A CN201610957004A CN106361875A CN 106361875 A CN106361875 A CN 106361875A CN 201610957004 A CN201610957004 A CN 201610957004A CN 106361875 A CN106361875 A CN 106361875A
- Authority
- CN
- China
- Prior art keywords
- extract
- compositionss
- quintessence oil
- oil
- folium mori
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title abstract description 29
- 230000035900 sweating Effects 0.000 title abstract 3
- 239000000284 extract Substances 0.000 claims abstract description 55
- 239000003921 oil Substances 0.000 claims description 24
- 241000628997 Flos Species 0.000 claims description 22
- 239000008589 Cortex Fraxini Substances 0.000 claims description 19
- 230000001166 anti-perspirative effect Effects 0.000 claims description 17
- 239000003213 antiperspirant Substances 0.000 claims description 17
- 239000003814 drug Substances 0.000 claims description 16
- -1 hydroxyl zirconium aluminum Chemical compound 0.000 claims description 10
- 230000000844 anti-bacterial effect Effects 0.000 claims description 9
- 239000000341 volatile oil Substances 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 239000000080 wetting agent Substances 0.000 claims description 6
- 238000005660 chlorination reaction Methods 0.000 claims description 5
- 239000003974 emollient agent Substances 0.000 claims description 5
- 229940069521 aloe extract Drugs 0.000 claims description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 4
- 230000036541 health Effects 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 230000002335 preservative effect Effects 0.000 claims description 4
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims description 3
- 241000208690 Hamamelis Species 0.000 claims description 3
- 240000003553 Leptospermum scoparium Species 0.000 claims description 3
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 3
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 2
- 244000246386 Mentha pulegium Species 0.000 claims description 2
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 2
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 2
- 235000010676 Ocimum basilicum Nutrition 0.000 claims description 2
- 240000007926 Ocimum gratissimum Species 0.000 claims description 2
- 244000178231 Rosmarinus officinalis Species 0.000 claims description 2
- 235000017803 cinnamon Nutrition 0.000 claims description 2
- 235000001050 hortel pimenta Nutrition 0.000 claims description 2
- 244000025254 Cannabis sativa Species 0.000 claims 1
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims 1
- 235000003140 Panax quinquefolius Nutrition 0.000 claims 1
- 230000003213 activating effect Effects 0.000 claims 1
- 235000008434 ginseng Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 17
- 238000002474 experimental method Methods 0.000 abstract description 6
- 239000000419 plant extract Substances 0.000 abstract description 6
- 240000006079 Schisandra chinensis Species 0.000 abstract description 3
- 240000000249 Morus alba Species 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 241000218378 Magnolia Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 230000002045 lasting effect Effects 0.000 abstract 1
- 239000002075 main ingredient Substances 0.000 abstract 1
- 230000035943 smell Effects 0.000 description 26
- 210000003491 skin Anatomy 0.000 description 23
- 230000002159 abnormal effect Effects 0.000 description 11
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 210000000804 eccrine gland Anatomy 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000012467 final product Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 210000000040 apocrine gland Anatomy 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 230000036760 body temperature Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 241000565359 Fraxinus chinensis Species 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229940112950 sage extract Drugs 0.000 description 3
- 235000020752 sage extract Nutrition 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- PPKXEPBICJTCRU-XMZRARIVSA-N (R,R)-tramadol hydrochloride Chemical compound Cl.COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 PPKXEPBICJTCRU-XMZRARIVSA-N 0.000 description 2
- 241000588214 Fraxinus chinensis subsp. rhynchophylla Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 108010043135 L-methionine gamma-lyase Proteins 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 159000000013 aluminium salts Chemical class 0.000 description 2
- 229910000329 aluminium sulfate Inorganic materials 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000036773 apocrine secretion Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000036751 eccrine secretion Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000000622 irritating effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940040145 liniment Drugs 0.000 description 2
- 239000000865 liniment Substances 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- PIRWNASAJNPKHT-SHZATDIYSA-N pamp Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)N)C(C)C)C1=CC=CC=C1 PIRWNASAJNPKHT-SHZATDIYSA-N 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 210000000106 sweat gland Anatomy 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- QWVUXEBWAZOACQ-UHFFFAOYSA-N 2-(hydroxymethyl)-2-[[2-hydroxy-3-(16-methylheptadecoxy)propoxy]methyl]propane-1,3-diol Chemical compound CC(C)CCCCCCCCCCCCCCCOCC(O)COCC(CO)(CO)CO QWVUXEBWAZOACQ-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 206010055000 Bromhidrosis Diseases 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- GMRNMZUSKYJXGJ-UHFFFAOYSA-N Fraxetin Natural products C1=CC(=O)C(=O)C2=C1C=C(OC)C(O)=C2O GMRNMZUSKYJXGJ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 241000007358 Magnolia biondii Species 0.000 description 1
- 240000005819 Magnolia denudata Species 0.000 description 1
- 241000007370 Magnolia sprengeri Species 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical group SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 240000003731 Piper cubeba Species 0.000 description 1
- 235000002711 Piper cubeba Nutrition 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 241000736078 Schisandra sphenanthera Species 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- HAVWRBANWNTOJX-UHFFFAOYSA-N fraxetin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2O HAVWRBANWNTOJX-UHFFFAOYSA-N 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 125000005456 glyceride group Chemical class 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 229960000789 guanidine hydrochloride Drugs 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- ZZHGIUCYKGFIPV-UHFFFAOYSA-M n-butylcarbamate Chemical compound CCCCNC([O-])=O ZZHGIUCYKGFIPV-UHFFFAOYSA-M 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001296 polysiloxane Chemical class 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000003009 skin protective agent Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 230000028016 temperature homeostasis Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000004577 thatch Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000004906 toe nail Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/28—Zirconium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
The invention provides a composition with sweating stopping and odor removing functions. The main ingredients of the composition are plant extracts including an ash bark extract, a magnolia flower extract, a Chinese magnoliavine fruit extract, a radix sophorae flavescentis extract, a mulberry leaf extract and the like. The composition has the sweating stopping and odor removing functions, the effects are rapid to achieve and lasting, the purpose can be achieved through multiple modes, and meanwhile experiment results show that the safety of the composition is good.
Description
Technical field
The invention belongs to chemical field, be related to a kind of there is hidroschesis eliminate the unusual smell the compositionss of function, more particularly to a kind of
The hidroschesis that has containing plant extract eliminates the unusual smell the compositionss of function.
Background technology
Perspire is that a lot of mammals including humans maintain and control the extremely important physiological function of body temperature.Row
Antiperspirant by aqueous water being become the phase change of water vapour and water vapour being evaporated the heat to distribute in body, thus preventing body
Temperature is too high, makes animal existence in hot environment.
The mankind are organized as sweat gland, including eccrine gland and two kinds of apocrine gland for perspire.Eccrine gland is used for adjusting body temperature, number
Measure as 2,000,000-400 ten thousand/people.Eccrine gland in foot distribution at most, is distributed less, its major function is to be arranged by skin at back
Antiperspirant, moisture evaporation make body temperature control at 37 DEG C about.The pressure of spiritual aspect also can cause the response of eccrine gland, causes to slap
The heart and sole perspire.Eccrine gland secretes the perspiration of 1-2l daily under normal circumstances.The composition of the perspiration of eccrine secretion depends on
The speed by sweat duct for the juice, its main component is water, and solids content (part by weight) is 0.03%-0.08%, and solid becomes
Divide and include sodium chloride, micro lactic acid and carbamide.
Apocrine gland be secretion abnormal smells from the patient body of gland, unrelated with thermoregulation, focus primarily upon oxter, circumference of eyes, scalp and
The positions such as genitals.Emotion changes can affect the secretion of apocrine gland.Eccrine gland can be with the substantial amounts of perspiration of rapid secretion, and apocrine gland
Perspiration is secreted with slower speed.The perspiration of apocrine secretion is viscous milk sample shape emulsion, containing protein, lipid, carbon water
Compound and salt.
In perspiring produced problem, the most bothersome is the abnormal flavour that oxter perspires generation.Perspiration be in itself aseptic,
Tasteless and colourless liquid, the secretions containing big eccrine gland.The generation of abnormal flavour is relevant with oxter bacterial number, its main source
It is the less apocrine secretion thing containing Organic substance of secretory volume.Eccrine secretion thing provides necessary moisture for bacterial growth,
Armpit hair provides, for apocrine gland perspiration, the place assembled again simultaneously, increases and is suitable to vegetative area.
At present, treatment body surface abnormal flavour mainly has fragrant screening method, antiperspirant method, sterilization several method.Fragrant screening method only relies on fragrance
Agent is difficult to complete covering smell；Antiperspirant method perspires to eliminate abnormal flavour using Drug inhibition such as aluminium salt, but medicine acting duration
Not long, body surface regenerates abnormal flavour after recovering to perspire；Sterilization adopts antibiotic etc to kill the antibacterial on pedal skin
Or funguses, make perspiration cannot decompose generation abnormal flavour, but sweat gland secretion perspiration is not acted on.All there is certain lacking in these methods
Fall into, therapeutic effect is unsatisfactory.
Content of the invention
For the defect overcoming " background technology " part to be reflected, the present invention provides a kind of having containing plant extract
Hidroschesis eliminates the unusual smell the compositionss of function, and the main component of said composition is Cortex Fraxini, Flos Magnoliae, Fructus Schisandrae Chinensis, Radix Sophorae Flavescentiss, Folium Mori extract.
The compositionss that a kind of hidroschesis eliminates the unusual smell, including Cortex Fraxini, Flos Magnoliae, Fructus Schisandrae Chinensis, Radix Sophorae Flavescentiss, Folium Mori extract, Cortex Fraxini, pungent
The name for ancient tribes in the east, Fructus Schisandrae Chinensis, Radix Sophorae Flavescentiss, the parts by weight of Folium Mori extract are:
Cortex Fraxini extract 0.01-5 part；
Flos Magnoliae extract 0.01-5 part；
Fructus Schisandrae Chinensis extrat 0.01-5 part；
Radix Sophorae Flavescentis extract 0.01-5 part；
Folium Mori extract 0.01-5 part.
Preferred version, Cortex Fraxini, Flos Magnoliae, Fructus Schisandrae Chinensis, Radix Sophorae Flavescentiss, the parts by weight of Folium Mori extract are:
Cortex Fraxini extract 0.01-3 part；
Flos Magnoliae extract 0.01-3 part；
Fructus Schisandrae Chinensis extrat 0.01-3 part；
Radix Sophorae Flavescentis extract 0.01-3 part；
Folium Mori extract 0.01-3 part.
More preferably scheme, Cortex Fraxini, Flos Magnoliae, Fructus Schisandrae Chinensis, Radix Sophorae Flavescentiss, the parts by weight of Folium Mori extract are:
Cortex Fraxini extract 0.01-1 part；
Flos Magnoliae extract 0.01-1 part；
Fructus Schisandrae Chinensis extrat 0.01-1 part；
Radix Sophorae Flavescentis extract 0.01-1 part；
Folium Mori extract 0.01-1 part.
Cortex Fraxini nature and flavor bitter cold, is heat clearing and damp drying Chinese medicine, has heat clearing and damp drying, astringent therapy effect.Modern pharmacological research shows the Qin
The fraxetin that skin contains being capable of effective hidroschesis.Fructus Schisandrae Chinensis sweet in the mouth, acid, warm in nature, tool is astringed the lung, and nourishing kidney is promoted the production of body fluid, receipts antiperspirant, arresting seminal emission effect,
For body void hidrosis, spontaneous perspiration, the disease such as night sweat.Flos Magnoliae is pungent, temperature, dispersing wind and cold, killing parasites for relieving itching.Radix Sophorae Flavescentiss heat clearing and damp drying, wind dispelling insecticide, main
Control skin pruritus, noxious dampness skin infection.Folium Mori are sweet, bitter, tremble with fear, dispelling wind and heat pathogens, clearing away lung-heat and moistening for dryness, liver heat removing and eyesight improving.Modern study shows Folium Mori
Extract has strong inhibitory action to methioninase, and methioninase is to decompose the human chitinase that Methionine is methanthiol, first sulfur
Alcohol is to lead to one of main component of bed body smell, therefore Folium Mori have the effect of significantly eliminating the unusual smell.Cortex Fraxini, the five tastes in composite formula
Son is monarch drug, restrains hidroschesis；Radix Sophorae Flavescentiss, Folium Mori are ministerial drug, heat clearing and damp drying；Flos Magnoliae is adjuvant drug, scattered wind anthelmintic.All medicines are worked in coordination with, and play altogether
Hidroschesis, the effect of eliminate the unusual smell.
Cortex Fraxini is Oleaceae plants fraxinus rhynchophylla Hance fraxinus rhynchophylla hance, Chinese ash fraxinus
Chinensis roxb., sharp leaf Chinese ash fraxinus szaboana lingelsh. or place post Chinese ash fraxinus
Stylosa lingelsh. is dried branch skin or dried bark.Fructus Schisandrae Chinensis are magnoliaceae schisandra schisandra
Chinensis (turcz.) baill.'s or schisandra chinensis schisandra sphenanthera rehd.et wils. is dry
Dry mature fruit.Flos Magnoliae is Magnoliacea plant Flos Magnoliae magnolia biondii pamp., Magnolia denudata magnolia denudata
Desv. or Flos Magnoliae magnolia sprengeri pamp. dry flower.Radix Sophorae Flavescentiss are leguminous plant Radix Sophorae Flavescentiss sophora
The dry root of flavescens ait..Folium Mori are the dried leaves of moraceae plants mulberry morus alba l..Above-mentioned Chinese medicine is all existing
The extracting solution of commercialization or extract, can directly buy from relevant market.
Further, compositionss also include antiperspirant, and antiperspirant can make compositionss have more excellent antiperspirant performance.Only
Diaphoretic is selected from the mixture of aluminium salt, zirconates or aluminum/zirconates, such as chlorination hydroxyl zirconium aluminum complex, the cooperation of chlorination hydroxyl zirconium aluminum glycine
One or more of thing, aluminum chloride.Antiperspirant is specifically chosen any or which is planted and is not particularly limited, people in the art
Member is practiced according to art technology routine.The parts by weight of antiperspirant are 5-25 part, and more preferably 5-20 part is optimum
Elect 10-18 part as.
Further, compositionss also include having skin moistening, releive, antiinflammatory, pain relieving, promote the conventional plant of wound healing function
Thing extract, such as hamamelis extract, sage extract, Aloe extract, Herba Equiseti Hiemalis extract, camomile extract, perfume (or spice)
Thatch extract.Aloe extract has the effect of skin moistening, Tramal.Camomile extract has that anti-inflammation and sterilization, Tramal are antipruritic, helps
The effect of wound healing.Hamamelis extract have antiinflammatory releive, restrain, the effect of antibacterial, can restrain pore, adjust oils and fatss and divide
Secrete, play moisturizing and only act in vain.Sage extract is astringent, peculiar smell removal agent, skin conditioner, skin protective agent, tool
Console, nourish, eliminate the unusual smell effect.Herba Equiseti Hiemalis extract be isostearyl glyceryl pentaerythrityl ether, skin conditioner, have console, nourishing effect.Herba Cymbopogonis Citrari carries
Thing tool sterilization fragrance is taken to eliminate the unusual smell effect.Above plant extract is specifically chosen any or which is planted and its in the composition
Parts by weight are not particularly limited, and those skilled in the art are practiced according to art technology routine.
Further, compositionss also include quintessence oil, such as Radix Vladimiriae quintessence oil, Herba Pogostemoniss quintessence oil, Cortex cinnamomi japonici (Ramulus Cinnamomi) quintessence oil, cinnamon spirit
Oil, Basil Essential, Herba Lysimachiae foenum-graeci quintessence oil, Flos Rosae Rugosae quintessence oil, sandalwood essential oil, Peppermint essential oil, cubeb litsen tree quintessence oil, Oleum Anisi Stellati, Herba Origani Vulgaris quintessence oil,
Tea tree ethereal oil, rosemary ethereal oil, further strengthen fragrance eliminate the unusual smell, bactericidal effect.Above-mentioned quintessence oil can use mill run,
Microencapsulation product can partly or entirely be adopted.Quintessence oil is specifically chosen any or which is planted and its weight portion in the composition
Number is not particularly limited, and those skilled in the art are practiced according to art technology routine.
Further, compositionss also include one of wetting agent, emollient, surfactant, antibacterial, preservative or
Multiple.Antibacterial can make compositionss have more excellent bactericidal property.Antibacterial include benzalkonium chloride, Bian rope oronain, poly- six
One or more of di-2-ethylhexylphosphine oxide guanidine hydrochloride, iodo propinyl n-butyl carbamate.Wetting agent can be trehalose, thoroughly
The conventional wetting agents such as bright matter acid sodium.Emollient can be hydro carbons, glyceride, ethers, fatty alcohol and silicone derivative etc..Sterilization
Agent, wetting agent, emollient, surfactant, the concrete species of preservative, composition and its parts by weight in the composition are no special
Different restriction, those skilled in the art are practiced according to art technology routine.
Live in above-described antiperspirant, conventional plant extract, quintessence oil and microencapsulation quintessence oil, wetting agent, emollient, surface
Property agent, antibacterial, preservative etc. all have been realized in commercialization, can directly from relevant market buy.
Compositions as described above, can be used in preparing the medicine that hidroschesis eliminates the unusual smell or health product (have hidroschesis remove different
Function of odor but other products of being not belonging to medicine can be considered as health product, for example there is hidroschesis and eliminate the unusual smell the specific use of function
Cosmetics).Said composition can realize, by various ways, the purposes that hidroschesis eliminates the unusual smell, for example, be configured to water preparation, gel, cream
Agent, emulsion formulations, spray agent, ballpoint preparation or stick formulation, wet tissue etc..
The compositionss that the hidroschesis that the present invention provides eliminates the unusual smell, have hidroschesis and the two kinds of functions that eliminate the unusual smell concurrently, rapid-action, effect is held
Long.The main component of compositionss is plant extract, test result indicate that the safety of said composition is good.
Specific embodiment
Below by embodiment, embodiments of the present invention are further illustrated.It should be noted that the present invention
Scope be not limited to described embodiment.Any technology essential factor in described embodiment is carried out identical or equivalent
Replace obtain technical scheme or those skilled in the art on the basis of described embodiment without creative work just
The technical scheme that can obtain, all should be contemplated as falling within protection scope of the present invention.
Compositionss embodiment 1-10:
Illustrate:
1st, the corresponding digital expression component parts by weight in the composition of each component in table.
2nd, the brij-35 in table represents Brij-35.
Embodiment 1-10 preparation method: weigh raw material by above formula, sequentially add, stirring and dissolving uniformly obtains final product medicinal liquid.
Above-mentioned medicinal liquid is loaded spray bottle, packs and obtain final product spray；Above-mentioned medicine liquid irrigation is loaded liniment bottle, obtains final product liniment；Will be above-mentioned
Medicinal liquid sprays or is impregnated on non-woven fabrics, and cutting sealing packaging obtains final product wet tissue.
Compositionss embodiment 11-17:
Illustrate:
1st, the corresponding digital expression component parts by weight in the composition of each component in table.
2nd, the brij-35 in table represents Brij-35.
Embodiment 11-17 preparation method: weigh raw material by above formula, sequentially add, stirring and dissolving uniformly obtains final product medicinal liquid.
Above-mentioned medicinal liquid is sprayed or is impregnated on non-woven fabrics, cutting sealing packaging obtains final product wet tissue.
Compositionss embodiment 18-20:
| Embodiment | 18 | 19 | 20 |
| Cortex Fraxini extract | 0.2 | 0.2 | 0.2 |
| Flos Magnoliae extract | 0.2 | 0.2 | 0.2 |
| Fructus Schisandrae Chinensis extrat | 0.2 | 0.2 | 0.2 |
| Radix Sophorae Flavescentis extract | 0.2 | 0.2 | 0.2 |
| Folium Mori extract | 0.2 | 0.2 | 0.2 |
| brij-35 | 4 | 10 | 12 |
| Propylene glycol | 5 | 5 | 5 |
| Chlorination hydroxyl zirconium aluminum aminoacetic acid complex | 20 | 20 | 20 |
| Aloe extract | \ | \ | 0.1 |
| Sage extract | 0.1 | 0.1 | 0.1 |
| Tea tree ethereal oil | 0.02 | 0.02 | 0.02 |
| Trehalose | 1 | 1 | 1 |
| Bian rope oronain | 0.05 | 0.05 | 0.05 |
| Vitamin e | 0.5 | 0.5 | 0.5 |
| Jojoba oil | 3 | 15 | 3 |
| Peg-26 glycerin ether | 3 | 3 | 3 |
| D- pantothenylol | 0.5 | 0.5 | 0.5 |
| 8% arabic gum | 8 | 4 | 4 |
| Glyceryl stearate | \ | 5 | \ |
| Water | 68.33 | 62.33 | 60.23 |
| Dosage form | Gel | Emulsifiable paste | Ballpoint |
Illustrate:
1st, the corresponding digital expression component parts by weight in the composition of each component in table.
2nd, the brij-35 in table represents Brij-35.
Embodiment 18-20 preparation method: weigh raw material by above formula, prepare by the common process of dosage form described in table,
This dosage form can be obtained.
Embodiment skin irritation evaluation experimental:
From healthy rabbits, male and female half and half, it is administered first 24 hours by back part of animal spinal column both sides with operating scissorss cropping not
Injured skin, goes gross area to be 10 × 10cm2, after unhairing, animal is randomly divided into intact skin group and damaged skin group, every group 5
Only, hair-fields will be gone on the left of intact skin group rabbit to give embodiment product, consumption 4g, right side blank (containing only pure water), after administration
Covered with one layer of sterilization oilpaper and two-layer antiseptic gauze, immobilization with adhesive tape.Before the administration of damaged skin group animal, skin coarse sandpaper is wiped
Hinder the skin of the left and right sides, to abrade epidermis, make similar toenail scrape the scratch grabbing generation, but must not bleeding, only scratch angle
Matter layer and lossless skin corium, medication is the same.Be administered latter 6 hours remove cover, observe respectively and record 1,24,48 hours to
Medicine position has or not situations such as erythema and edema.Every animal test results carry out skin irritation reaction scoring by table 1, calculate flat
All score values, embodiment appraisal result is shown in Table 2, table 3.
Table 1 skin irritation reacts standards of grading
Table 2 embodiment is to intact skin irritative response result
Table 3 embodiment is to damaged skin irritative response result
Test result indicate that, example composition is zero to rabbit normal skin irritant reaction score value, shows nonirritant.
The average response value that example composition stimulates to injured skin is also zero, shows to injured skin also nonirritant.
Embodiment eliminate the unusual smell effect assessment experiment:
Using olfactory test method, 20 bromhidrosis volunteers, age 18-30 year, patient is divided with slight/severe, i.e. opposite
Check apart from 30cm, exposed can smell abnormal smells from the patient person be slight, directly smell abnormal smells from the patient the greater for severe, every 4 patients are one group,
Include 1 severe volunteer, 3 slight volunteers respectively.Apply oxter with example composition respectively, consumption is 4g, Ran Houjin
Row is evaluated, and the elimination abnormal flavour persistent period averages.Carry out next group experiment, until whole embodiments compositionss are evaluated after 15 days
Complete.Embodiment evaluation result is shown in Table 4.
Table 4 embodiment eliminates the unusual smell effect
| Embodiment | Onset time | Persistent period |
| 1 | Immediately | 2 days |
| 2 | Immediately | 2 days |
| 3 | Immediately | 3 days |
| 4 | Immediately | 3 days |
| 5 | Immediately | 3 days |
| 6 | Immediately | 3 days |
| 7 | Immediately | 2 days |
| 8 | Immediately | 3 days |
| 9 | Immediately | 4 days |
| 10 | Immediately | 4 days |
| 11 | Immediately | 4 days |
| 12 | Immediately | 4 days |
| 13 | Immediately | 4 days |
| 14 | Immediately | 4 days |
| 15 | Immediately | 4 days |
| 16 | Immediately | 4 days |
| 17 | Immediately | 4 days |
| 18 | Immediately | 4 days |
| 19 | Immediately | 4 days |
| 20 | Immediately | 4 days |
Test result indicate that, example composition has splendid dispelling abnormal flavor effect.Meanwhile, no any in experimentation
Situations such as one embodiment cenesthesia exception, red swelling of the skin, occurs it was demonstrated that embodiment product is to armpit skin nonirritant.
Embodiment antiperspirancy performance evaluation experimental:
Using 2003 editions methods of fda " otc hidroschesis medicine validity test standard ", example composition antiperspirancy performance is entered
Row test.3g example composition is sprayed or is coated in the oxter of 30 female volunteers, carry out the experiment of hot room, calculate average antiperspirant weight
Decrement.Every 5 volunteers of embodiment, carry out next group experiment, until whole embodiments compositionss evaluation completes after 15 days.Real
Test and the results are shown in Table 5.
Table 5 embodiment of the present invention antiperspirancy performance
Test result indicate that, example composition is respectively provided with splendid antiperspirant efficacy.Meanwhile, stingless in experimentation
Swash, allergy situations such as occur it was demonstrated that the safety of example composition is good.
When the medicine being eliminated the unusual smell using the hidroschesis of example composition preparation or health product, original amounts can be according to except different
3g-4g compositionss are once sprayed or are coated in body by the usage amount in the experiment of taste effect assessment or antiperspirancy performance evaluation experimental
Table, afterwards Different Individual suitably increase and decrease consumption according to practical effect.
Claims (10)
1. the compositionss that a kind of hidroschesis eliminates the unusual smell are it is characterised in that described compositionss include Cortex Fraxini, Flos Magnoliae, Fructus Schisandrae Chinensis, hardship
Ginseng, Folium Mori extract, described Cortex Fraxini, Flos Magnoliae, Fructus Schisandrae Chinensis, Radix Sophorae Flavescentiss, the parts by weight of Folium Mori extract are:
Cortex Fraxini extract 0.01-5 part；
Flos Magnoliae extract 0.01-5 part；
Fructus Schisandrae Chinensis extrat 0.01-5 part；
Radix Sophorae Flavescentis extract 0.01-5 part；
Folium Mori extract 0.01-5 part.
2. compositionss according to claim 1 are it is characterised in that described Cortex Fraxini, Flos Magnoliae, Fructus Schisandrae Chinensis, Radix Sophorae Flavescentiss, Folium Mori carry
Take thing parts by weight be:
Cortex Fraxini extract 0.01-3 part；
Flos Magnoliae extract 0.01-3 part；
Fructus Schisandrae Chinensis extrat 0.01-3 part；
Radix Sophorae Flavescentis extract 0.01-3 part；
Folium Mori extract 0.01-3 part.
3. compositionss according to claim 1 are it is characterised in that described Cortex Fraxini, Flos Magnoliae, Fructus Schisandrae Chinensis, Radix Sophorae Flavescentiss, Folium Mori carry
The parts by weight taking thing are:
Cortex Fraxini extract 0.01-1 part；
Flos Magnoliae extract 0.01-1 part；
Fructus Schisandrae Chinensis extrat 0.01-1 part；
Radix Sophorae Flavescentis extract 0.01-1 part；
Folium Mori extract 0.01-1 part.
4. the compositionss according to any one of claim 1-3 are it is characterised in that described compositionss also include antiperspirant,
Described antiperspirant is one or more of chlorination hydroxyl zirconium aluminum complex, chlorination hydroxyl zirconium aluminum aminoacetic acid complex, aluminum chloride,
The parts by weight of described antiperspirant are 5-25 part.
5. compositionss according to claim 4 are it is characterised in that the parts by weight of described antiperspirant are 10-18 part.
6. compositionss according to claim 4 are it is characterised in that described compositionss also include hamamelis extract, Mus
One or more of tail grass extract, Aloe extract, Herba Equiseti Hiemalis extract, camomile extract, Herba Cymbopogonis Citrari extract.
7. compositionss according to claim 6 are it is characterised in that described compositionss also include quintessence oil, described quintessence oil
For Radix Vladimiriae quintessence oil, Herba Pogostemoniss quintessence oil, Cortex cinnamomi japonici (Ramulus Cinnamomi) quintessence oil, cinnamon essential oil, Basil Essential, Herba Lysimachiae foenum-graeci quintessence oil, Flos Rosae Rugosae quintessence oil, Lignum Santali Albi essence
One or more of oil, Peppermint essential oil, Oleum Anisi Stellati, Herba Origani Vulgaris quintessence oil, tea tree ethereal oil, rosemary ethereal oil.
8. compositionss according to claim 7 are it is characterised in that described quintessence oil is partly or entirely microencapsulation quintessence oil.
9. compositionss according to claim 7 are it is characterised in that described compositionss also include wetting agent, emollient, table
One or more of face activating agent, antibacterial, preservative.
10. the compositionss described in any one of claim 1-9 are for preparing the purposes of the medicine that hidroschesis eliminates the unusual smell or health product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610957004.8A CN106361875A (en) | 2016-11-04 | 2016-11-04 | Composition with sweating stopping and odor removing functions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610957004.8A CN106361875A (en) | 2016-11-04 | 2016-11-04 | Composition with sweating stopping and odor removing functions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106361875A true CN106361875A (en) | 2017-02-01 |
Family
ID=57892904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610957004.8A Pending CN106361875A (en) | 2016-11-04 | 2016-11-04 | Composition with sweating stopping and odor removing functions |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106361875A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108478480A (en) * | 2018-04-08 | 2018-09-04 | 广东名辰堂健康产业股份有限公司 | A kind of hidroschesis is dispelled smelly topical composition and preparation method thereof |
| CN109077958A (en) * | 2018-08-31 | 2018-12-25 | 蒋春霞 | A kind of antiperspirant composition and preparation method thereof |
| CN115737481A (en) * | 2022-12-08 | 2023-03-07 | 深圳市理然化妆品有限公司 | Sweat-inhibiting, sterilizing and deodorizing composition |
| CN118453475A (en) * | 2024-05-23 | 2024-08-09 | 广东兆禧健康产业投资有限公司 | Antibacterial antiperspirant cream containing agarwood |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103230354A (en) * | 2013-05-03 | 2013-08-07 | 肇庆迪彩日化科技有限公司 | Sweating suppression deodorant composition |
-
2016
- 2016-11-04 CN CN201610957004.8A patent/CN106361875A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103230354A (en) * | 2013-05-03 | 2013-08-07 | 肇庆迪彩日化科技有限公司 | Sweating suppression deodorant composition |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108478480A (en) * | 2018-04-08 | 2018-09-04 | 广东名辰堂健康产业股份有限公司 | A kind of hidroschesis is dispelled smelly topical composition and preparation method thereof |
| CN109077958A (en) * | 2018-08-31 | 2018-12-25 | 蒋春霞 | A kind of antiperspirant composition and preparation method thereof |
| CN115737481A (en) * | 2022-12-08 | 2023-03-07 | 深圳市理然化妆品有限公司 | Sweat-inhibiting, sterilizing and deodorizing composition |
| CN118453475A (en) * | 2024-05-23 | 2024-08-09 | 广东兆禧健康产业投资有限公司 | Antibacterial antiperspirant cream containing agarwood |
| CN118453475B (en) * | 2024-05-23 | 2025-01-28 | 广东兆禧健康产业投资有限公司 | Antibacterial antiperspirant cream containing agarwood |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101584742B1 (en) | Cosmetic composition for improving skin-aging | |
| CN104940050A (en) | Use of agilawood volatile oil stoste in preparation of skin-care product | |
| KR20200138142A (en) | A cosmetic composition for skin improvement comprising bulb extract | |
| KR20080002279A (en) | Cosmetic composition for lips with the effect of improving atopic symptoms | |
| KR102037030B1 (en) | Cosmetic composition for improving acne containing Phytosilica | |
| US20150147415A1 (en) | Agent for promoting hair growth and method for preparing same | |
| CN106361875A (en) | Composition with sweating stopping and odor removing functions | |
| KR101332215B1 (en) | Cosmetic composition containing fermentated complex of extracts with cryptomeria japonica and nelumbo nucifera for acne improvement and enhancing immune system | |
| KR102189330B1 (en) | A cosmetic composition for skin improvement comprising bulb extract | |
| CN108078871B (en) | A kind of mouthwash of the rare saponin(e containing Radix Notoginseng and preparation method thereof | |
| CN106176323A (en) | Plants essential oil Skin whitening care cosmetics | |
| KR101764131B1 (en) | External preparation for skin comprising aloe extracts and capsaicin | |
| KR20030077509A (en) | A hygienic band and manufacturing include chinese herb medicine a composite | |
| CN102872240B (en) | Compound essential oil for relaxing and activating collaterals | |
| KR101950331B1 (en) | Compositions for decreasing sebum and improving acne comprising extracts of Pinus densiflora leaf, Artemisia annua and Citrus junos fruit | |
| CN106344460A (en) | Special moisturizing and acne-removing face cream for acne-prone skin and preparation method thereof | |
| JPH04124138A (en) | External preparation for skin | |
| KR101221183B1 (en) | Skin external composition containing Korean medicinal flower extracts | |
| CN111346026A (en) | Plant extract skin-moistening emulsion composition and preparation method thereof | |
| CN106137003A (en) | The antibacterial compound essential Oil of stuffy nose relieving, paper for daily use and preparation method thereof | |
| KR20200074287A (en) | Composition for Improving Skin Condition or for Quasi-Drugs, Comprising Plant Extracts | |
| KR20190048930A (en) | Cosmetic composition for reducing skin stimulus by vitamine c | |
| CN104138499B (en) | A kind of Chinese medicine composition, its preparation method and its application for treating tinea of feet and hands and onychomycosis | |
| CN113876852A (en) | Antibacterial anti-inflammatory and antiallergic composition as well as preparation method and application thereof | |
| CN113925907A (en) | Antibacterial anti-inflammatory and antiallergic composition as well as preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170201 |